The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study
The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study: Development and External Validation of an International, Multicenter Machine Learning Algorithm for Prediction of Anastomotic Insufficiency After Colonic or Colorectal Anastomosis
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
Basel
-
Allschwil, Basel, Switzerland, 4123
- Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
-
-
Zürich
-
Winterthur, Zürich, Switzerland, 8401
- Kantonsspital Winterthur
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who underwent colon or colorectal anastomosis for neoplasia, diverticulitis, mesenterial ischemia, iatrogenic or traumatic perforation, or inflammatory bowel disease
Exclusion Criteria:
- age < 18
- recurrent colorectal cancer
- peritoneal carcinomatosis or unresectable metastatic disease at time of bowel resection
- informed consent not obtainable
- follow-up < 6 weeks after surgery
- no reversal of and ostomy
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of Anastomotic leak
Time Frame: 5 years
|
Occurrence of anastomotic insufficiency/leak is defined as any clinical signs of leakage, confirmed by radiological examination, endoscopy, clinical examination of the anastomosis, or upon reoperation.
|
5 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of Death
Time Frame: 90 days
|
90 days
|
|
|
Time to diagnosis of anastomotic leak
Time Frame: 90 days
|
Time to diagnosis of a leakage will be calculated as days between the index operation and diagnosis of the leakage by imaging with extraluminal contrast, endoscopy, re-operation, or when fecal containing fluid is objectified in a drainage.
|
90 days
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disease-free survival (months)
Time Frame: 5 years
|
5 years
|
|
|
Overall survival (months)
Time Frame: 5 years
|
5 years
|
|
|
Adjuvant/additive immunochemotherapy (yes/no)
Time Frame: 5 years
|
Did the patient receive adjuvant/additive immunochemotherapy after surgery?
(yes/no)
|
5 years
|
|
Adjuvant/additive radiotherapy (yes/no)
Time Frame: 5 years
|
Did the patient receive adjuvant/additive radiotherapy after surgery?
(yes/no)
|
5 years
|
|
Additive curative surgery (no/yes: liver; lung; locoragional relapse)
Time Frame: 5 years
|
Did the patient receive additive curative surgery after the initial intervention?
(no/yes: liver; lung; locoragional relapse)
|
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Michel Adamina, Prof. Dr. med., Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
- Principal Investigator: Anas Taha, Dr. med., None currently
- Principal Investigator: Thomas Steffen, Cantonal Hospital of St. Gallen
- Principal Investigator: Stephanie Taha-Mehlitz, Dr. med., Department of Visceral Surgery, Clarunis, University Hospital Basel, Basel, Switzerland
- Principal Investigator: Frédéric Ris, Prof. Dr. med., Department of Surgery, Hôpitaux Universitaires de Genève
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Peritoneal Diseases
- Postoperative Complications
- Gastrointestinal Diseases
- Gastroenteritis
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Inflammatory Bowel Diseases
- Ischemia
- Crohn Disease
- Anastomotic Leak
- Diverticulum
- Diverticular Diseases
- Mesenteric Ischemia
Other Study ID Numbers
Other Study ID Numbers
- PANIC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.